Research: Canadian researchers discover pathway to developing universal flu vaccines

VANCOUVER, British Columbia — University of British Columbia researchers may have found a way to develop universal flu vaccines and eliminate the need for seasonal flu vaccinations, university officials announced Tuesday.

Led by John Schrader, Canada Research chair in Immunology and director of UBC's Biomedical Research Centre, the research team found that the 2009 H1N1 "swine flu" vaccine triggers antibodies that protect against many influenza viruses, including the lethal avian H5N1 "bird flu" strain. "The flu virus has a protein called hemagglutinin, or HA for short. This protein is like a flower with a head and a stem," Schrader noted. "The flu virus binds to human cells via the head of the HA, much like a socket and plug," he added. "Current flu vaccines target the head of the HA to prevent infections, but because the flu virus mutates very quickly, this part of the HA changes rapidly, hence the need for different vaccines every flu season."

Vaccines contain bits of weak or dead germs that prompt the human immune system to produce antibodies that circulate in the blood to kill those specific germs. However, the research team found that the 2009 pandemic H1N1 vaccine induced broadly protective antibodies capable of fighting different variants of the flu virus.

"This is because, rather than attacking the variable head of the HA, the antibodies attacked the stem of the HA, neutralizing the flu virus," Schrader stated. "The stem plays such an integral role in penetrating the cell that it cannot change between different variants of the flu virus."

The new discovery could pave the way to developing universal flu vaccines, Schrader suggested.

Schrader theorizes that a vaccine based on a mixture of influenza viruses not circulating in humans but in animals should have the same effect and potentially make influenza pandemics and seasonal influenza a thing of the past.

Details have been published May 8 in the journal Frontiers in Immunology.


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.